BIOTECHNOLOGY VALUE FUND L P 13D/13G Filings for Arcus Biosciences, Inc. (RCUS)

BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Arcus Biosciences, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2023-02-14
11:58 am
Sale		 2022-12-31 13G Arcus Biosciences, Inc.
RCUS		 BIOTECHNOLOGY VALUE FUND L P 2,303,520
3.200%		 -1,657,428decrease
(-41.84%)		 Filing
2022-03-14
4:48 pm
Purchase		 2022-03-03 13G Arcus Biosciences, Inc.
RCUS		 BIOTECHNOLOGY VALUE FUND L P 3,960,948
5.600%		 1,208,726increase
(+43.92%)		 Filing
2020-12-10
5:16 pm
Sale		 2020-02-04 13G Arcus Biosciences, Inc.
RCUS		 BIOTECHNOLOGY VALUE FUND L P 2,752,222
4.200%		 -826,801decrease
(-23.10%)		 Filing